Title
Higher prevalence of unrecognized kidney disease at high altitude
Date Issued
01 April 2018
Access level
open access
Resource Type
journal article
Author(s)
Plata-Cornejo R.
Cornejo A.
Sharma S.
Swenson E.R.
Johnson R.J.
Pando J.
Publisher(s)
Springer International Publishing
Abstract
Background: High altitude renal syndrome has been described in populations with excessive erythrocytosis. We evaluated whether high altitude (HA) dwellers might be at increased risk for kidney disease. Methods: We performed a cross-sectional study to investigate differences in prevalence of kidney function and metabolic syndrome in healthy subjects living at HA vs. sea level (SL) without any known history of hypertension, diabetes or chronic kidney disease. Results: We examined 293 subjects, aged 40 to 60 years: 125 SL (154 m) and 168 HA (3640 m) dwellers. HA dwellers had higher serum creatinine, lower estimated glomerular function rate (eGFR) (69.5 ± 15.2 vs. 102.1 ± 17.8 ml/min/1.73 m 2 , p < 0.0001), more proteinuria and higher hemoglobin concentrations compared to SL subjects. HA subjects had a lower prevalence of metabolic syndrome. Hemoglobin concentrations correlated inversely with eGFR in female (p = 0.001) and male (p = 0.03) HA dwellers. Using logistic regression analysis to compare subjects with eGFR < 90 vs. > 90 ml/min/1.73 m 2 , a lower eGFR was associated with female gender (odds ratio adjusted: 5.65 [95% confidence interval: 2.43–13.13]; p = 0.001), high altitude (14.78 [6.46–33.79]; p = 0.001), hemoglobin (1.68 [1.16–2.43]; p = 0.001) and uric acid (1.93 [1.36–2.72]; p = 0.001). Conclusions: Dwellers at high altitude who are considered healthy have worse kidney function, a higher prevalence of proteinuria and a lower prevalence of metabolic syndrome compared to people living at SL.
Start page
263
End page
269
Volume
31
Issue
2
Language
English
Subjects
Scopus EID
2-s2.0-85034656199
PubMed ID
Source
Journal of Nephrology
ISSN of the container
11218428
Sponsor(s)
Acknowledgements We thank to Ronald Guillen MD, Marco Antonio Pariente MD, Claudia Ferrer MD Griselda Calisaya from Instituto de Nefrología, La Paz-Bolivia. Raquel Cancino MD, Luis Gonzales MD, Enrique Hernandez MD, Ivan Seminario MD, Jose Luis León MD from Hospital Nacional Arzobispo Loayza, Lima-Peru for their contribution for this work. This study was partially supported by a Grant no. 03-018 from the “International Society of Nephrology (ISN) Global Outreach Research and Prevention Committee”.
Sources of information:
Directorio de Producción Científica
Scopus